General enquiries about RegMed XB can be directed to email@example.com.
For more specific questions pertaining to the Phase 1 projects, you may wish to contact the health foundations:
Members of the press should contact Marcel Hammink (m: +31 6 53 21 39 17, e: firstname.lastname@example.org).
Companies or private partners interested in participating should email Marianne van der Steen (email@example.com).
Questions from scientists or about the scientific ambition of RegMed XB can be directed to Vanessa LaPointe (firstname.lastname@example.org).
Any other enquiries about RegMed XB can be directed to email@example.com.